General pharmacological profile and effects of E-4716, a novel histamine receptor blocker, on the central nervous system

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 20, Issue 3, 1998, Pages 199-210

  Fisas, M A ^a   Gutierrez B ^a   Fort, M ^a   Dordal, A ^a   Garcia C ^a   Farre A J ^a  

^a Laboratorios Dr Esteve SA   (Spain)

Author keywords

E 4716; Histamine receptor blockers; Mapinastine

Indexed keywords

ANTIHISTAMINIC AGENT; ASTEMIZOLE; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CLEMASTINE; DIPHENHYDRAMINE; EBASTINE; MAPINASTINE; MEPYRAMINE; PHENYLQUINONE; PROMETHAZINE; TERFENADINE; UNCLASSIFIED DRUG;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; DRUG ACTIVITY; DRUG EFFECT; DRUG POTENTIATION; HYPNOSIS; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; RECEPTOR AFFINITY;

ANIMALS; BARBITURATES; BENZIMIDAZOLES; CENTRAL NERVOUS SYSTEM; CHLORDIAZEPOXIDE; DRUG SYNERGISM; ETHANOL; GUINEA PIGS; HISTAMINE H1 ANTAGONISTS; MACACA FASCICULARIS; MALE; MICE; RABBITS; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; RECEPTORS, CELL SURFACE;

EID: 0031831988     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Heykans, J.J.P., Snoeck, E., Awouters, F., Peer, A. Antihistamines. In: The In Vivo Study of Drug Action. C.J. Van Boxtel (Ed.). Elsevier Science Publishers: Amsterdam 1992, 337-56.
2. Aaronson, D.W. Effects of terfenadine on psychomotor performance: An overview. Drug Safety 1993, 8(4): 321-30.
3. 1 antihistaminic compound. Arch Int Pharmacodyn 1981, 251: 39-51.
4. 1-receptor antagonists. Comparative tolerability and safety. Drug Safety 1994, 10(5): 350-80.
5. Gutiérrez, B., Dordal, A., Fort, M., Galicia, J., Farré, A.J. Effect of mapinastine, a new antihistaminic with antiallergic properties, against chemical mediators inductors of immunologic reactions. Meth Find Exp Clin Pharmacol 1996, 18(6): 397-406.
6. 1-antihistamine E-4716 in the guinea pig in vivo. Meth Find Exp Clin Pharmacol 1996, 18(7): 465-73.
7. Hukovick, S. Responses of the isolated sympathetic nerve-ductus deferens preparation of the guinea-pig. Br J Pharmacol 1961, 16: 188-94.
8. 2-receptors. Nature 1972, 236: 385-90.
9. Quintana, A. Effects of pimozide on the responses of smooth muscle to nondopamine agonist and calcium. Eur J Pharmacol 1978, 53: 113-6.
10. 3H-prazosin to rat brain α-adrenergic receptors. Eur J Pharmacol 1979, 55: 323-6.
11. 2-Adrenergic agonists/antagonists: The synthesis and structure-activity relationships of a series of indolin-2-yl and tetrahyroquinotin-2-yl imidazolines. J Med Chem 1987, 30: 1555-62.
12. 2-noradrenergic receptors in brain, heart, and lung membranes. J Biol Chem 1978, 253: 5090-102.
13. 2-adrenoceptor. Eur J Pharmacol 1986, 130: 137-9.
14. 3H]-SCH 23390, a selective D-I receptor antagonist ligand, in rat striatum. Life Sci 1984, 35: 1885-93.
15. Kholer, C., Hall, H., Ogren, S., Gawell, L. A potent substituted benzamide drug with high affinity for dopamine D-2 receptor in the rat brain. Biochem Pharmacol 1985, 34(13): 2251-9.
16. 3-histamine receptor subtypes. Mol Pharmacol 1990, 38: 610-3.
17. 3H] pirenzepine and quinuclidinyl benzilate binding to muscarine cholinergic receptors in rat brain. J Pharmacol Exp Ther 1984, 228: 648-55.
18. 2 muscarinic receptor subtypes. Life Sci 1983, 32: 3001-11.
19. Buckley, N.J., Bonner, T.I., Buckley, C.M., Brann, M.R. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-KI cells. Mol Pharmacol 1989, 35: 469-76.
20. 1 binding sites in rabbit lung, chicken heart, and N108-15 cells. Mol Pharmacol 1990, 35: 457-64.
21. 1C Binding sites in rat frontal cortex. J Neurochem 1986, 47(2): 529-40.
22. Nikam, S.S., Martin, A.R., Nelson, D.L. Serotonergic properties of spiroxatrine enantiomers. J Med Chem 1988, 31: 1965-8.
23. 3 receptors in rat using radioligand binding. Nature 1987, 330 (24/31): 746-8.
24. Irwin, S. Drugs screening and evaluative procedures. Science 1962, 136: 123-8.
25. Awouters, F., Niemegeers, C.J.E., Lemaerts, F.M., Janssen, P.A.J. Delay of castor oil diarrhoea in rats: A new way to evaluate inhibitors of prostaglandin biosynthesis. J Pharmacol Pharmacol 1978, 30: 41-5.
26. Siegmund E., Cadmus, R., Lu, G. A method for evaluating both non-narcotic and narcotic analgesics. Proc Soc Exp Biol Med 1957, 95: 729-31.
27. Niemegeers, C.S.E. The anticonvulsant properties of anxiolytic agents. In: Anxiolytics. Fielding, S. (Ed.). Futura Publishing: New York 1979, 141-58.
28. Randall, L.O., Bagdon, R.E. Pharmacology of iproniazid and other amine oxidase inhibitors. Ann NY Acad Sci 1959, 80: 626-42.
29. Niemegeers, C.J.E., Lenaerts, F.M., Artois, K.S.K., Janssen, P.A.J. Interaction of drugs with apomorphine, tryptamine and norepinephrine. A new "in vivo" approach: The ATN-Test in rats. Arch Int Pharmacodyn 1977, 227: 238-53.
30. 2+ antagonists. General Pharmacol 1991, 22(1): 177-81.
31. Guliérrez, B., Vilumara, A., Farré, A.J. Inhibition of aconitine induced mortality in the conscious rat: A screening test for antiarrhythmic drugs. Met Find Exp Clin Pharmacol 1987, 9(5): 307-10.
32. P'ans, S.V., Cariate, P., Timen, E., Gardocky, J.F. Tremorine antagonism studies with a new anticholinergic agent, oxyphencyclimine. Arch Int Pharmacodyn 1959, 120: 222-8.
33. Allen, L.E., Ferguson, H.A., Cox, R.H. Pharmacologic effects of MJ 9022-1, a potential tranquilizing agent. Arzneim Forsh/Drug Res 1974, 24(6): 917-22.
34. Nicholson, A.N. New antihistamines free of sedative side-effects. TIPS 1987, 8: 247-9.
35. 1 receptors? J Pharm Pharmacol 1979, 31: 701-2.
36. 2 antagonists. Neuropharmacol 1985, 24: 245-50.
37. 1-receptors labeled in vivo: Antidepressant and antihistamine interactions. Eur J Pharm 1980, 64: 177-81.
38. 14C]E-4716 after a single administration in rats and dogs. Meth Find Exp Clin Pharmacol 1997, 19(6): 407-15.